Hyperlysinemia, Type I, also known as hyperlysinemia, is related to 2,4-dienoyl-coa reductase deficiency and argininemia, and has symptoms including seizures An important gene associated with Hyperlysinemia, Type I is AASS (Aminoadipate-Semialdehyde Synthase), and among its related pathways/superpathways are Metabolism and Regulation of expression of SLITs and ROBOs. Affiliated tissues include cortex and kidney, and related phenotypes are intellectual disability and seizure